{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:16:24Z","timestamp":1791821784010,"version":"4.3.4"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01048","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T04:59:57Z","timestamp":1591160397000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":134,"title":["Vaccines Against Antimicrobial Resistance"],"prefix":"10.3389","volume":"11","author":[{"given":"Roberto","family":"Rosini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Nicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S0140-6736(09)61460-4","article-title":"Ageing populations: the challenges ahead","volume":"374","author":"Christensen","year":"2009","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1098\/rstb.2011.0075","article-title":"Twenty-first century vaccines","volume":"366","author":"Rappuoli","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12288","DOI":"10.1073\/pnas.1402981111","article-title":"Vaccines, new opportunities for a new society","volume":"111","author":"Rappuoli","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/d41586-017-08323-0","article-title":"Deploy vaccines to fight superbugs","volume":"552","author":"Rappuoli","year":"2017","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-1-4557-0090-5.00017-3","article-title":"A short history of vaccination","author":"Plotkin","year":"2013","journal-title":"Vaccines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/1751-7915.12388","article-title":"Antibiotic drug discovery","volume":"9","author":"Wohlleben","year":"2016","journal-title":"Microb Biotechnol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol Mol Biol Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas Aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol Adv"},{"key":"B9","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"P T"},{"key":"B10","doi-asserted-by":"publisher","first-page":"a012476","DOI":"10.1101\/cshperspect.a012476","article-title":"Vaccines, reverse vaccinology, and bacterial pathogenesis","volume":"3","author":"Delany","year":"2013","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"E11988","DOI":"10.1073\/pnas.1810840115","article-title":"Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora","volume":"115","author":"Tedijanto","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular mechanisms of antibacterial multidrug resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol Spectr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/s41467-018-03949-8","article-title":"Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species","volume":"9","author":"Baker","year":"2018","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: a rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect Drug Resist"},{"key":"B17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jac\/dks373","article-title":"Transposon library screening for identification of genetic loci participating in intrinsic susceptibility and acquired resistance to antistaphylococcal agents","volume":"68","author":"Blake","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"B18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrmicro1614","article-title":"The antibiotic resistome: the nexus of chemical and genetic diversity","volume":"5","author":"Wright","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjm.2016.10.002","article-title":"Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on beta-lactams and polymyxins","volume":"47","author":"Sampaio","year":"2016","journal-title":"Braz J Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.14822.1","article-title":"Treatment of extended-spectrum\u03b2-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now?","volume":"7","author":"Pana","year":"2018","journal-title":"F1000Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the versatile beta-lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/21505594.2017.1292196","article-title":"Therapeutic options for carbapenem-resistant Enterobacteriaceae infections","volume":"8","author":"Trecarichi","year":"2017","journal-title":"Virulence"},{"key":"B23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.scitotenv.2019.01.179","article-title":"Whole genome sequencing reveals resemblance between ESBL-producing and carbapenem resistant Klebsiella pneumoniae isolates from Austrian rivers and clinical isolates from hospitals","volume":"662","author":"Lepuschitz","year":"2019","journal-title":"Sci Total Environ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"taz036","DOI":"10.1093\/jtm\/taz036","article-title":"Global geographic trends in antimicrobial resistance: the role of international travel","volume":"26","author":"Frost","year":"2019","journal-title":"J. Travel Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1128\/AAC.00809-12","article-title":"Identification of a novel genomic island conferring resistance to multiple aminoglycoside antibiotics in Campylobacter Coli","volume":"56","author":"Qin","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3389\/fmicb.2016.01265","article-title":"Genomic analysis reveals multi-drug resistance clusters in group B Streptococcus CC17 hypervirulent isolates causing neonatal invasive disease in southern mainland China","volume":"7","author":"Campisi","year":"2016","journal-title":"Front Microbiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","article-title":"Multidrug resistance in bacteria","volume":"78","author":"Nikaido","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijantimicag.2012.10.010","article-title":"An adaptive response of Enterobacter Aerogenes to imipenem: regulation of porin balance in clinical isolates","volume":"41","author":"Lavigne","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"B29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/ki.1995.374","article-title":"Structure and function of the porin channel","volume":"48","author":"Welte","year":"1995","journal-title":"Kidney Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijmm.2011.10.001","article-title":"Structure and function of OprD protein in Pseudomonas Aeruginosa: from antibiotic resistance to novel therapies","volume":"302","author":"Li","year":"2012","journal-title":"Int J Med Microbiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2217\/fmb.14.66","article-title":"Multidrug efflux pumps in gram-negative bacteria and their role in antibiotic resistance","volume":"9","author":"Blair","year":"2014","journal-title":"Future Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1128\/JB.01502-05","article-title":"Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia Coli mutant without mutations in marRAB or acrRAB","volume":"188","author":"Nicoloff","year":"2006","journal-title":"J Bacteriol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"12798","DOI":"10.1093\/nar\/gkx929","article-title":"CsrA maximizes expression of the AcrAB multidrug resistance transporter","volume":"45","author":"Ricci","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e00187","DOI":"10.1128\/mBio.00187-11","article-title":"A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria Gonorrhoeae","volume":"2","author":"Ohneck","year":"2011","journal-title":"MBio"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/jac\/dkm041","article-title":"Emergence of a Streptococcus Pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of Pneumococcal Pneumonia","volume":"59","author":"Cattoir","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1128\/AAC.01548-10","article-title":"Emergence of linezolid-resistant mutants in a susceptible-cell population of methicillin-resistant Staphylococcus Aureus","volume":"55","author":"Ikeda-Dantsuji","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e01586","DOI":"10.1128\/AAC.01586-18","article-title":"Investigation of novel pmrB and eptA mutations in isogenic acinetobacter baumannii isolates associated with colistin resistance and increased virulence in vivo","volume":"63","author":"Gerson","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"B38","article-title":"Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis","year":"2017"},{"key":"B39","volume-title":"Antibiotic Resistance Threats in the United States","year":"2019"},{"key":"B40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1517\/14656561003596350","article-title":"Treatment of acinetobacter infections","volume":"11","author":"Michalopoulos","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jhin.2019.09.021","article-title":"Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter Baumannii","volume":"104","author":"Nasr","year":"2019","journal-title":"J Hosp Infect"},{"key":"B42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium Tuberculosis: mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2013.11.011","article-title":"Mycolic acids: structures, biosynthesis, and beyond","volume":"21","author":"Marrakchi","year":"2014","journal-title":"Chem Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5588\/ijtld.16.0716","article-title":"Isoniazid-resistant tuberculosis: a cause for concern?","volume":"21","author":"Stagg","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","article-title":"Neisseria Gonorrhoeae: drug resistance, mouse models, and vaccine development","volume":"71","author":"Rice","year":"2017","journal-title":"Annu Rev Microbiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e000239","DOI":"10.1099\/mgen.0.000239","article-title":"Using genomics to understand antimicrobial resistance and transmission in Neisseria Gonorrhoeae","volume":"5","author":"Sanchez-Buso","year":"2019","journal-title":"Microb Genom"},{"key":"B47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro.2017.169","article-title":"Neisseria Gonorrhoeae host adaptation and pathogenesis","volume":"16","author":"Quillin","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.EI10-0009-2015","article-title":"Antimicrobial resistance expressed by neisseria gonorrhoeae: a major global public health problem in the 21st century","volume":"4","author":"Unemo","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B49","doi-asserted-by":"publisher","first-page":"iv36","DOI":"10.1128\/microbiolspec.ARBA-0009-2017","article-title":"Antimicrobial resistance: a one health perspective","volume":"6","author":"McEwen","year":"2018","journal-title":"Microbiol Spectr"},{"key":"B50","doi-asserted-by":"publisher","first-page":"12868","DOI":"10.1073\/pnas.1717157115","article-title":"Antimicrobial resistance and the role of vaccines","volume":"115","author":"Bloom","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B51","doi-asserted-by":"publisher","first-page":"12902","DOI":"10.1073\/pnas.1717163115","article-title":"Microbiome as a tool and a target in the effort to address antimicrobial resistance","volume":"115","author":"Relman","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B52","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S1473-3099(10)70277-2","article-title":"Global spread of New Delhi metallo-\u03b2-lactamase 1","volume":"10","author":"Leverstein-Van Hall","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0976-500X.124405","article-title":"Dry antibiotic pipeline: regulatory bottlenecks and regulatory reforms","volume":"5","author":"Gupta","year":"2014","journal-title":"J Pharmacol Pharmacother"},{"key":"B55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nature22308","article-title":"Predictive compound accumulation rules yield a broad-spectrum antibiotic","volume":"545","author":"Richter","year":"2017","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"20162562","DOI":"10.1098\/rspb.2016.2562","article-title":"Why does drug resistance readily evolve but vaccine resistance does not?","volume":"284","author":"Kennedy","year":"2017","journal-title":"Proc Biol Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3389\/fimmu.2018.01068","article-title":"Changing priorities in vaccinology: antibiotic resistance moving to the top","volume":"9","author":"Tagliabue","year":"2018","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJMoa070844","article-title":"Effectiveness of influenza vaccine in the community-dwelling elderly","volume":"357","author":"Nichol","year":"2007","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1086\/605087","article-title":"The effect of universal influenza immunization on antibiotic prescriptions: an ecological study","volume":"49","author":"Kwong","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e0208211","DOI":"10.1371\/journal.pone.0208211","article-title":"Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus Pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil","volume":"13","author":"Cassiolato","year":"2018","journal-title":"PLoS ONE"},{"key":"B62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/jpids\/piw005","article-title":"The effect of 13-valent pneumococcal conjugate vaccine on the serotype distribution and antibiotic resistance profiles in children with invasive pneumococcal disease","volume":"6","author":"Gaviria-Agudelo","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B63","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/EDE.0000000000001092","article-title":"Hospitalizations associated with respiratory syncytial virus and influenza in children, including children diagnosed with asthma","volume":"30","author":"Goldstein","year":"2019","journal-title":"Epidemiology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","article-title":"The serogroup B meningococcal vaccine bexsero elicits antibodies to Neisseria Gonorrhoeae","volume":"69","author":"Semchenko","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e01668","DOI":"10.1128\/mBio.01668-19","article-title":"Genetic similarity of gonococcal homologs to meningococcal outer membrane proteins of serogroup B vaccine","volume":"10","author":"Marjuki","year":"2019","journal-title":"MBio"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.2147\/IDR.S159952","article-title":"Meningococcal group B vaccine for the prevention of invasive meningococcal disease caused by Neisseria Meningitidis serogroup B. Infect Drug Resist","volume":"12","author":"Rivero-Calle","year":"2019"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.4161\/hv.28428","article-title":"Vaccines against Clostridium difficile","volume":"10","author":"Leuzzi","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"B68","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/14760584.2018.1488590","article-title":"Escherichia Coli and Staphylococcus Aureus: leading bacterial pathogens of healthcare associated infections and bacteremia in older-age populations","volume":"17","author":"Poolman","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens5010022","article-title":"The role of Staphylococcus aureus virulence factors in skin infection and their potential as vaccine antigens","volume":"5","author":"Lacey","year":"2016","journal-title":"Pathogens."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1080\/14760584.2016.1179583","article-title":"Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention","volume":"15","author":"Dayan","year":"2016","journal-title":"Expert Rev Vaccines."},{"key":"B71","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nrmicro2668","article-title":"The development of vaccines: how the past led to the future","volume":"9","author":"Plotkin","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward Jenner and the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"D. (2015). Live attenuated vaccines: historical successes and current challenges","volume":"480","author":"Minor","year":"","journal-title":"Virology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fimmu.2014.00012","article-title":"Designing vaccines for the twenty-first century society","volume":"5","author":"Finco","year":"2014","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1017\/S0022172400008172","article-title":"Duration of passive immunity","volume":"22","author":"Glenny","year":"1923","journal-title":"J Hyg."},{"key":"B76","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.2683073","article-title":"Mutants of pertussis toxin suitable for vaccine development","volume":"246","author":"Pizza","year":"1989","journal-title":"Science"},{"key":"B77","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/14760584.2017.1338569","article-title":"The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience","volume":"16","author":"van den Ende","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"B78","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms18010020","article-title":"Reverse genetics approaches for the development of influenza vaccines","volume":"18","author":"Nogales","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.4161\/hv.7.10.16794","article-title":"13-valent pneumococcal conjugate vaccine (PCV13)","volume":"7","author":"Jefferies","year":"2011","journal-title":"Hum Vaccin"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1098\/rstb.2011.0032","article-title":"Contribution of vaccines to our understanding of pneumococcal disease","volume":"366","author":"Klugman","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S1473-3099(17)30108-1","article-title":"Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia Coli. in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial","volume":"17","author":"Huttner","year":"","journal-title":"Lancet Infect. Dis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/glycob\/cwz044","article-title":"Characterization and immunogenicity of a shigella flexneri 2a O-antigen bioconjugate vaccine candidate","volume":"29","author":"Ravenscroft","year":"2019","journal-title":"Glycobiology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s12272-017-0969-z","article-title":"Vaccine adjuvants: smart components to boost the immune system","volume":"40","author":"Bastola","year":"2017","journal-title":"Arch Pharm Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1016\/j.vaccine.2019.07.098","article-title":"Adjuvant Systems for vaccines: 13years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood","volume":"37","author":"Laupeze","year":"2019","journal-title":"Vaccine"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine."},{"key":"B88","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria Gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"key":"B90","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1073\/pnas.1717160115","article-title":"Technologies to address antimicrobial resistance","volume":"115","author":"Baker","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B91","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2019.00022","article-title":"Nanoparticle-based vaccines against respiratory viruses","volume":"10","author":"Al-Halifa","year":"2019","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","article-title":"Self-assembling protein nanoparticles in the design of vaccines","volume":"14","author":"Lopez-Sagaseta","year":"2016","journal-title":"Comput Struct Biotechnol J"},{"key":"B93","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J Exp Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J Virol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"B96","doi-asserted-by":"publisher","first-page":"91ra62","DOI":"10.1126\/scitranslmed.3002234","article-title":"Rational design of a meningococcal antigen inducing broad protective immunity","volume":"3","author":"Scarselli","year":"2011","journal-title":"Sci Transl Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3389\/fmicb.2015.01320","article-title":"Approval of raxibacumab for the treatment of inhalation anthrax under the US food and drug administration animal rule","volume":"6","author":"Tsai","year":"2015","journal-title":"Front Microbiol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1177\/1060028017713029","article-title":"Obiltoxaximab: adding to the treatment arsenal for Bacillus Anthracis infection","volume":"51","author":"Hou","year":"2017","journal-title":"Ann Pharmacother"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/phar.1990","article-title":"Bezlotoxumab: a novel agent for the prevention of recurrent Clostridium difficile infection","volume":"37","author":"Kufel","year":"2017","journal-title":"Pharmacotherapy"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3389\/fimmu.2019.01722","article-title":"Vaccine evolution and its application to fight modern threats","volume":"10","author":"Andreano","year":"2019","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.vaccine.2016.11.040","article-title":"Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens","volume":"35","author":"Maruggi","year":"2017","journal-title":"Vaccine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13756-019-0472-z","article-title":"Using the best available data to estimate the cost of antimicrobial resistance: a systematic review","volume":"8","author":"Wozniak","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"B103","doi-asserted-by":"publisher","first-page":"12911","DOI":"10.1073\/pnas.1717161115","article-title":"Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR","volume":"115","author":"Sevilla","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B104","doi-asserted-by":"publisher","first-page":"eaau4679","DOI":"10.1126\/science.aau4679","article-title":"The challenge of antimicrobial resistance: what economics can contribute","volume":"364","author":"Roope","year":"2019","journal-title":"Science"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1335163","DOI":"10.1080\/20016689.2017.1335163","article-title":"2. How is the economic assessment of vaccines performed today?","volume":"5","author":"Standaert","year":"2017","journal-title":"J Mark Access Health Policy"},{"key":"B106","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01048\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T08:43:11Z","timestamp":1595320991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01048\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":106,"alternative-id":["10.3389\/fimmu.2020.01048"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01048","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"article-number":"1048"}}